Regulation of pharmaceuticals is a complex task. Andreas Seiter's note reviews the role of drug regulatory authorities in developing countries and discusses how to set priorities in line with the overall health policy agenda.. Most diseases in developing countries could be treated with existing and well-known medicines. However, essential pharmaceuticals often are not available, not accessible, or not used appropriately. As bad or worse, use of substandard...
انظر المزيد
تفاصيل
-
2005/4/01
-
مذكرة موجزة
-
32194
-
1
-
1
-
2005/5/04
-
Disclosed
-
Pharmaceuticals: drug regulation in low and middle income countries
-
economic regulatory framework